The DOI matches its Crossref record.
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial
Abstract
Objective: To explore the impact of an early treatment response on maintenance of work capacity in patients with early, active rheumatoid arthritis (RA). Methods: In the Finnish Rheumatoid Arthritis Combination Therapy trial, 195 patients with recent‐onset RA were randomized to receive either a combination of disease‐modifying antirheumatic drugs (DMARDs) with prednisolone or a single DMARD with or without prednisolone for 2 years. Treatment responses were evaluated according to the American College of Rheumatology (ACR) criteria. After a 5‐year followup, the cumulative number of days of sick leave and RA‐related permanent work disability was calculated for each of the 162 patients who were available for the active work force at baseline. Results: Of the 159 patients assessed at 6 months, 29 were in clinical remission, 66 achieved an ACR50 response but not remission, 29 achieved an ACR20 response but not an ACR50 response, and 35 failed to achieve an ACR20 response. In these 4 groups, the median numbers of work disability days per patient‐year from 6 months through 60 months of followup were 0 (interquartile range [IQR] 0–3), 4 (IQR 0–131), 16 (IQR 0–170), and 352 (16–365), respectively (P < 0.001). Pairwise multiple comparisons showed a statistically significant difference between all groups except the ACR50 and ACR20 groups. At 12 months, 30 patients were in remission. None of the 44 patients in remission at 6 or 12 months became permanently work disabled over the 5‐year followup, as compared with 15 patients in the ACR50 group (23%), 6 in the ACR20 group (21%), and 19 without an ACR20 response at 6 months (56%). Conclusion: Prompt induction of remission translates into maintenance of work capacity. At 6 months, an ACR50 response is no better than an ACR20 response with regard to future productivity, while failure to achieve an ACR20 response carries a high risk for work disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
PINCUS, T., SWEARINGEN, C. J., BERGMAN, M., & YAZICI, Y. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080182 · Cited by 349
Sokka, T., Kautiainen, H., Pincus, T., Verstappen, S. M., Aggarwal, A., Alten, R., Andersone, D., Badsha, H., Baecklund, E., Belmonte, M., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2951 · Cited by 284
Self-citationWesthoff, G., Buttgereit, F., Gromnica-Ihle, E., & Zink, A. (2008) · Rheumatology · doi:10.1093/rheumatology/ken137 · Cited by 66
Metadata
- Authors
- Puolakka, K., Kautiainen, H., Möttönen, T., Hannonen, P., Korpela, M., Hakala, M., Järvinen, P., Ahonen, J., Forsberg, S., & Leirisalo‐Repo, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 52
- Issue
- 1
- Pages
- 36-41
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2031988556
- Cited by
- 229
- References
- 0
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial. https://app.cochat.ai/papers/10.1002/art.20716
- The paper
- Puolakka, K., Kautiainen, H., Möttönen, T., Hannonen, P., Korpela, M., Hakala, M., Järvinen, P., Ahonen, J., Forsberg, S., & Leirisalo‐Repo, M. (2005). Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial. Arthritis & Rheumatism. https://doi.org/10.1002/art.20716
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.